Startseite › Kolorektales Karzinom › Oregon › Portland
Klinische Studien zu Kolorektales Karzinom in Portland, OR
28 Studien zu Kolorektales Karzinom suchen Teilnehmer an Standorten in und um Portland (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Teilnehmer gesuchtPhase 3
- Compass Oncology - Rose Quarter /ID# 280127, Portland
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Teilnehmer gesucht
- Oregon Health & Science University (Knight Cancer Institute), Portland
Family Communications After Genetic Testing
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mi entfernt
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Oregon Health & Science University (OHSU), Portland
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Teilnehmer gesuchtPhase 2
- Oregon Health and Science University, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mi entfernt
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1
- Exelixis Clinical Site #51, Portland
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Teilnehmer gesuchtPhase 1
- ALX Center 6, Portland
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Teilnehmer gesuchtPhase 1
- Research Site, Portland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Teilnehmer gesuchtPhase 3
- Kaiser Permanente Interstate Medical Office Central, Portland
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Teilnehmer gesuchtPhase 3
- Oregon Health And Science University, Portland
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Research Site, Portland
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Teilnehmer gesuchtPhase 3
- Oregon Health And Science University, Portland
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Teilnehmer gesuchtPhase 3
- Oregon Health and Science University, Portland
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Teilnehmer gesuchtPhase 2
- Research Site, Portland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Oregon Health and Science University, Portland
A Study of MGC026 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Providence Cancer Institute, Portland
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Oregon Health & Science University, Portland
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Investigative Site #121, Portland
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Teilnehmer gesuchtPhase 3
- Providence Cancer Institute Franz Clinic, Portland
- Providence Portland Medical Center, Portland
- Providence Oncology and Hematology Care Clinic - Westside, Portland
- und 5 weitere
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
Teilnehmer gesuchtPhase 2
- OHSU Knight Cancer Institute, Portland
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Teilnehmer gesuchtPhase 2
- Northwest Cancer Specialists /ID# 275151, Portland
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Teilnehmer gesuchtPhase 2
- Northwest Cancer Specialists - Compass, Portland
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Teilnehmer gesuchtPhase 3Gesunde Freiwillige willkommen
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mi entfernt
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Teilnehmer gesuchtBeobachtungsstudie
- Kaiser Permanente Northwest, Portland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Oregon Health Sciences University, Portland
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Teilnehmer gesuchtBeobachtungsstudie
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mi entfernt
Evaluation of Gixam's Performance in a FIT Negative Population
Teilnehmer gesuchtPhase 2
- The Oregon Clinic Gastroenterology-East, Portland
Kolorektales Karzinom-Studien in anderen Städten
- Houston, TX102 Studien
- New York City, NY78 Studien
- Nashville, TN69 Studien
- Boston, MA63 Studien
- Los Angeles, CA59 Studien
- Arlington, VA52 Studien
- St. Louis, MO50 Studien
- San Antonio, TX46 Studien
- Philadelphia, PA44 Studien
- Grand Rapids, MI40 Studien
- Baldwin Park, CA37 Studien
- Chicago, IL34 Studien
Weitere Studien in Portland
- Nichtkleinzelliges Lungenkarzinom46 Studien
- Krebs (alle Arten)34 Studien
- Brustkrebs33 Studien
- Prostatakrebs33 Studien
- Metastasierender Krebs29 Studien
- Eierstockkrebs27 Studien
- Lungenkrebs26 Studien
- Akute myeloische Leukämie25 Studien
- Endometriumkarzinom24 Studien
- Plattenepithelkarzinom im Kopf-Hals-Bereich19 Studien
- Bauchspeicheldrüsenkrebs19 Studien
- Herzinsuffizienz17 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.